These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1720496)
1. Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies. Preisegger KH; Zatloukal K; Spurej G; Denk H Liver; 1991 Oct; 11(5):300-9. PubMed ID: 1720496 [TBL] [Abstract][Full Text] [Related]
2. Excretory function in cultured hepatocytes from griseofulvin-treated mice. Kawahara H; Marceau N; French SW Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150 [TBL] [Abstract][Full Text] [Related]
3. Enzyme-histochemical studies of griseofulvin-intoxicated mouse livers. Woltsche M; Zatloukal K; Denk H Liver; 1991 Aug; 11(4):231-40. PubMed ID: 1658525 [TBL] [Abstract][Full Text] [Related]
4. Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver. Hutter H; Zatloukal K; Winter G; Stumptner C; Denk H Lab Invest; 1993 Nov; 69(5):576-82. PubMed ID: 7504119 [TBL] [Abstract][Full Text] [Related]
5. Ultrastructural, biochemical, and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides. Franke WW; Denk H; Schmid E; Osborn M; Weber K Lab Invest; 1979 Feb; 40(2):207-20. PubMed ID: 219290 [TBL] [Abstract][Full Text] [Related]
6. Fate of Mallory body-containing hepatocytes: disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin-treated mouse. Zatloukal K; Spurej G; Rainer I; Lackinger E; Denk H Hepatology; 1990 Apr; 11(4):652-61. PubMed ID: 1691733 [TBL] [Abstract][Full Text] [Related]
7. Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Hazan R; Denk H; Franke WW; Lackinger E; Schiller DL Lab Invest; 1986 May; 54(5):543-53. PubMed ID: 2422438 [TBL] [Abstract][Full Text] [Related]
8. Mallory body filaments become insoluble after normal assembly into intermediate filaments. Pollanen MS; Markiewicz P; Weyer L; Goh MC; Bergeron C Am J Pathol; 1994 Nov; 145(5):1140-7. PubMed ID: 7526693 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130 [TBL] [Abstract][Full Text] [Related]
10. High molecular weight component of Mallory bodies detected by a monoclonal antibody. Zatloukal K; Denk H; Spurej G; Lackinger E; Preisegger KH; Franke WW Lab Invest; 1990 Apr; 62(4):427-34. PubMed ID: 1692099 [TBL] [Abstract][Full Text] [Related]
11. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter. Zatloukal K; Böck G; Rainer I; Denk H; Weber K Lab Invest; 1991 Feb; 64(2):200-6. PubMed ID: 1705301 [TBL] [Abstract][Full Text] [Related]
12. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products. Preisegger KH; Stumptner C; Riegelnegg D; Brown PC; Silverman JA; Thorgeirsson SS; Denk H Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270 [TBL] [Abstract][Full Text] [Related]
13. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Cadrin M; Anderson NM; Aasheim LH; Kawahara H; Franks DJ; French SW Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860 [TBL] [Abstract][Full Text] [Related]
14. Pathology of cytoskeleton of liver cells: demonstration of mallory bodies (alcoholic hyalin) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes. Denk H; Franke WW; Dragosics B; Zeiler I Hepatology; 1981; 1(1):9-20. PubMed ID: 6169613 [No Abstract] [Full Text] [Related]
15. Cytokeratin of apparent high molecular weight in livers from griseofulvin-fed mice. Cadrin M; Marceau N; French SW J Hepatol; 1992 Mar; 14(2-3):226-31. PubMed ID: 1380022 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies. Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653 [TBL] [Abstract][Full Text] [Related]
17. Common epitopes of human and murine Mallory bodies and Lewy bodies as revealed by a neurofilament antibody. Preisegger KH; Zatloukal K; Spurej G; Riegelnegg D; Denk H Lab Invest; 1992 Feb; 66(2):193-9. PubMed ID: 1370966 [TBL] [Abstract][Full Text] [Related]
18. On the three-dimensional structure of quick-frozen hepatic Mallory bodies with special reference to the appearance of cytoplasmic vesicles. Irie T; Koyama W; Ikeuchi Y; Kanaseki T Cell Struct Funct; 1991 Feb; 16(1):1-16. PubMed ID: 1709594 [TBL] [Abstract][Full Text] [Related]
19. Disorganisation of intermediate filament structure in alcoholic and other liver diseases. Barbatis C; Morton J; Woods JC; Burns J; Bradley J; McGee JO Gut; 1986 Jul; 27(7):765-70. PubMed ID: 3732887 [TBL] [Abstract][Full Text] [Related]
20. Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins. Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H J Hepatol; 2003 Apr; 38(4):387-94. PubMed ID: 12663227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]